Free Trial

Teladoc Health (TDOC) Stock Price, News & Analysis

-0.23 (-2.20%)
(As of 06/12/2024 ET)
Today's Range
50-Day Range
52-Week Range
4.68 million shs
Average Volume
4.76 million shs
Market Capitalization
$1.73 billion
P/E Ratio
Dividend Yield
Price Target

Teladoc Health MarketRank™ Stock Analysis

Analyst Rating
2.33 Rating Score
78.5% Upside
$18.22 Price Target
Short Interest
16.52% of Shares Sold Short
Dividend Strength
News Sentiment
0.28mentions of Teladoc Health in the last 14 days
Based on 22 Articles This Week
Insider Trading
Selling Shares
$521,043 Sold Last Quarter
Proj. Earnings Growth
From ($1.05) to ($0.72) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.77 out of 5 stars

Medical Sector

405th out of 913 stocks

Offices & Clinics Of Medical Doctors Industry

4th out of 6 stocks

TDOC stock logo

About Teladoc Health Stock (NYSE:TDOC)

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

TDOC Stock Price History

TDOC Stock News Headlines

Hims & Hers Health Soars on Generic GLP-1 Rollout Plans (TDOC)
Him & Hers Health Inc. (NYSE: HIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments
Doximity is the Facebook and LinkedIn of the Medical Community (TDOC)
Doximity stock is surging as analysts and investors are taking note of the cloud-based digital platform's strong revenue and earnings growth
LifeMD Can Surge on Its GLP-1 Offerings (TDOC)
LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a result
Teladoc Health (NYSE:TDOC) Reaches New 52-Week Low at $10.62
Teladoc Health Names Chuck Divita as CEO
3 Cathie Wood Stocks That Could Be Coiled Springs
See More Headlines
Receive TDOC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teladoc Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Offices & clinics of medical doctors
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
18 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$2.60 billion
Cash Flow
$0.78 per share
Book Value
$14.05 per share


Free Float
Market Cap
$1.73 billion

Social Links

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

TDOC Stock Analysis - Frequently Asked Questions

Should I buy or sell Teladoc Health stock right now?

18 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 12 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" TDOC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TDOC, but not buy additional shares or sell existing shares.
View TDOC analyst ratings
or view top-rated stocks.

What is Teladoc Health's stock price target for 2024?

18 Wall Street analysts have issued 12 month price targets for Teladoc Health's stock. Their TDOC share price targets range from $13.50 to $25.00. On average, they predict the company's share price to reach $18.22 in the next year. This suggests a possible upside of 78.5% from the stock's current price.
View analysts price targets for TDOC
or view top-rated stocks among Wall Street analysts.

How have TDOC shares performed in 2024?

Teladoc Health's stock was trading at $21.55 at the beginning of the year. Since then, TDOC stock has decreased by 52.6% and is now trading at $10.2050.
View the best growth stocks for 2024 here

When is Teladoc Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 23rd 2024.
View our TDOC earnings forecast

How were Teladoc Health's earnings last quarter?

Teladoc Health, Inc. (NYSE:TDOC) announced its quarterly earnings results on Thursday, April, 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.47) by $0.02. The health services provider had revenue of $646.13 million for the quarter, compared to analysts' expectations of $637.31 million. Teladoc Health had a negative net margin of 8.90% and a negative trailing twelve-month return on equity of 10.13%. Teladoc Health's revenue was up 2.7% on a year-over-year basis. During the same period in the prior year, the company earned ($0.37) earnings per share.

What guidance has Teladoc Health issued on next quarter's earnings?

Teladoc Health updated its second quarter 2024 earnings guidance on Thursday, April, 25th. The company provided earnings per share guidance of -0.450--0.350 for the period, compared to the consensus earnings per share estimate of -0.300. The company issued revenue guidance of $635.0 million-$660.0 million, compared to the consensus revenue estimate of $662.6 million.

What is Jason Gorevic's approval rating as Teladoc Health's CEO?

106 employees have rated Teladoc Health Chief Executive Officer Jason Gorevic on Jason Gorevic has an approval rating of 95% among the company's employees. This puts Jason Gorevic in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Teladoc Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Block (SQ), Shopify (SHOP), DocuSign (DOCU), Salesforce (CRM), PayPal (PYPL) and Zoom Video Communications (ZM).

When did Teladoc Health IPO?

Teladoc Health (TDOC) raised $112 million in an initial public offering on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Who are Teladoc Health's major shareholders?

Teladoc Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (10.23%), Sumitomo Mitsui Trust Holdings Inc. (4.24%), Nikko Asset Management Americas Inc. (4.23%), Simplex Trading LLC (0.00%), PEAK6 Investments LLC (0.00%) and Swiss National Bank (0.19%). Insiders that own company stock include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, Claus Torp Jensen, Daniel Trencher, David William Sides, James L Cave, Jason N Gorevic, Karen L Daniel, Laizer Kornwasser, Mala Murthy, Michael Willem Waters, Nikolaos P Nanis, Richard J Napolitano, Sandra L Fenwick, Stephany Verstraete and Vidya Raman-Tangella.
View institutional ownership trends

How do I buy shares of Teladoc Health?

Shares of TDOC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Teladoc Health have any subsidiaries?
The following companies are subsidiares of Teladoc Health: AM Healthcare Management Consulting Sdn. Bhd., AMHMS - Health Care Management Services S.A., Advance Holdco Limited, Advance Medical, Advance Medical - Serviços de Consultoria e Gestão de Dados Ltda, Advance Medical Health Care Management Services Chile S.A., Advance Medical Hungary Tanácsadó és Szolgáltató Korlátolt Felelösségü Társaság, Advance Medical Inc., AmeriDoc, Best Doctors, Best Doctors Australasia Pty Limited, Best Doctors Holdings Inc., Best Doctors Inc., Best Doctors International Insurance S.a.r.l., Best Doctors Portugal Ltd., BetterHelp, CogCubed, Compile Inc., Consult A Doctor, HY Holdings Inc., Healthiest You, Institute of Patient Safety and Quality in Virtual Care LLC, Intouch Health, Livongo, MedecinDirect, Médecin Direct, Rise Health Inc., Stat Doctors, Stat Health LLC, TELADOC HEALTH INTERNATIONAL SOCIEDAD ANÓNIMA, TelaDietitian, Teladoc Health Canada Inc., Teladoc Health Massachusetts Holdings Inc., Teladoc Health UK Ltd., and Yi Yi Medical Health Management Consulting (Shanghai) Co. Ltd..
Read More
This page (NYSE:TDOC) was last updated on 6/13/2024 by Staff

From Our Partners